Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat

British Journal of Nutrition

Volumn 97, Issue 4, 2007, Pages 770-775

  Suzuki, Yasushi A ^a   Tomoda, Mayuko ^a   Muratal, Yuji ^b   Inui, Hiroshi ^b   Sugiura, Masaki ^a,b   Nakano, Yoshihisa ^b  

^a SARAYA CO LTD   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Antidiabetic effects; Diabetes; Insulin response; Siraitia grosvenori Swingle; Sugar substitutes

Indexed keywords

ALBUMIN; GLUCOSE; INSULIN; PLANT EXTRACT; SIRAITIA GROSVENORI EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG EFFECT; FOOD INTAKE; GOTO KAKIZAKI RAT; INSULIN RELEASE; LIPID PEROXIDATION; LONG TERM CARE; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS; RAT; SIRAITIA GROSVENORI; URINE VOLUME;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CUCURBITACEAE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EATING; GLUCOSE TOLERANCE TEST; INSULIN; LIPID PEROXIDATION; MALE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS; SIRAITIA;

EID: 33947519147     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507381300     Document Type: Article

References (28)

1. +- glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism 49, 990-995.
2. Bisbis S, Bailbe D, Tormo MA, Picarel-Blanchot F, Derouet M, Simon J & Portha B (1993) Insulin resistance in the GK rat: Decreased receptor number but normal kinase activity in the liver. Am J Physiol 265, E807-E813.
3. Chiasson JL, Josse RG, Leiter LA, et al. (1996) The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19, 1190-1193.
4. Clissold SP & Edwards C (1988) Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35, 214-243.
5. Goto Y & Kakizaki M (1981) The spontaneous-diabetes rat: A model of noninsulin-dependent diabetes mellitus. Proc Jpn Acad 57, 381-384.
6. Goto Y, Kakizaki M & Masaki N (1975) Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc Jpn Acad 51, 80-85.
7. Hossen MA, Shinmei Y, Jiang S, Takubo M, Tsumuro T, Murata Y, Suguira M & Kamei C (2005) Effect of Lo Han Kuo (Siraitia grosvenori Swingle) on nasal rubbing and scratching behavior in ICR mice. Biol Pharm Bull 28, 238-241.
8. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y & Yamada Y (1999) Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48, 927-932.
9. Ihara Y, Yamada Y, Toyokuni S, et al. (2000) Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 473, 24-46.
10. Janssen U, Phillips AO & Floege J (1999) Rodent models of nephropathy associated with type II diabetes. J Nephrol 12, 159-172.
11. Kasai R, Nie RL, Nashi K, Ohtani K, Zhou J, Tao GD & Tanaka O (1989) Sweet cucurbitane glycosides from fruits of Siraitia samensis (chi-zi luo-han-guo), a Chinese folk medicine. Agric Biol Chem 53, 3347-3349.
12. Lee C (1975) Intense sweetener from lo han kuo (Momordica grosvenori). Experientia 31, 533-534.
13. Matsumoto K, Kasai R, Ohtani K & Tanaka O (1990) Minor cucurbitane-glycosides from fruits of Siraitia grosvenori (Cucurbitaceae). Chem Pharm Bull 38, 2030-2032.
14. Movassat J, Saulnier C, Serradas P & Portha B (1997) Impaired development of pancreatic β-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 40, 916-925.
15. National Research Council (1985) Guide for the Care and Use of Laboratory Animals. Publication no. 85-23, revised ed.Bethesda, MA: National Institute of Health.
16. Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
17. O'Rourke CM, Davis JA, Saltiel AR & Cornicell JA (1997) Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus. Metabolism 46, 192-198.
18. Ostenson CG, Khan A, Abdel-Halim SM, Guenifi A, Suzuki K, Goto Y & Efendic S (1993) Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 36, 3-8.
19. Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y & Giroix MH (1991) β Cell insensitivity to glucose in GK rat, a spontaneous non-obese model for type 2 (non insulin-dependent) diabetes. Diabetes 40, 486-496.
20. Rury RH, Robert CT & Carole AC (1999) A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22, 960-964.
21. Saito N, Sakai H, Sekihara H & Yajima Y (1998) Effect of an α-glucosidase inhibitor (voglibose), in combination with sulponilureas, on glycemic control in type 2 diabetes patients. J Intern Med Res 26, 219-232.
22. Suzuki YA, Murata Y, Inui H, Sugiura M & Nakano Y (2005) Triterpene glycosides of Siraitia grosvenori inhibit rat intestinal maltase and suppress the rise in plasma glucose level after single oral administration of maltose in rats. J Agric Food Chem 53, 2941-2946.
23. Takasaki M, Konoshima T, Murata Y, Sugiura M, Nishino H, Tokuda H, Matsumoto K, Kasai R & Yamasaki K (2003) Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Lett 198, 37-42.
24. Takemoto T, Arihara S, Nakajima T & Okuhira M (1983) Studies on the constituents of Fructus momordicae. I. On the sweet principle. Yakugaku Zasshi 11, 1151-1154.
25. Takeo E, Yoshida H, Tada N, et al. (2002) Sweet element of Siraitia grosvenori inhibit oxidative modification of low-density lipoprotein. J Atherosclerosis Thromb 9, 114-120.
26. Toeller M (1994) α-Glucosidase inhibitors in diabetes: Efficacy in NIDDM subjects. Eur J Clin Invest 24, Suppl. 3, 31-35.
27. Wada R, Koyama M, Mizukami H, Odaka H, Ikeda H & Yagihashi S (1999) Effects of long-term treatment with α-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: A genetic model for type 2 diabetes. Diabetes Metab Res Rev 15, 332-337.
28. Zhou YP, Ostenson CG, Ling ZC & Grill V (1995) Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats. Endocrinology 136, 3546-3551.